SpotitEarly
SpotitEarly, Inc.
SpotitEarly, Inc. is a biotechnology startup developing a non-invasive, at-home breath test for the early detection of multiple cancers. The company utilizes a unique bio-hybrid approach that combines the superior olfactory senses of trained canines with a proprietary artificial intelligence platform to analyze breath samples. This method aims to make early cancer screening more accessible, accurate, and less invasive than traditional procedures.
Products & Team
At-Home Early Cancer Detection Breath Test
This is a non-invasive screening tool for the early detection of breast, lung, colorectal, and prostate cancers. Consumers use an at-home kit to provide a breath sample, which is then mailed to SpotitEarly's lab for analysis. At the lab, trained canines sniff the sample, and their physiological and behavioral signals are monitored by the LUCID AI platform to determine the result.
The test addresses the critical issue of low participation in early cancer screening by providing a more accessible, affordable, and less invasive alternative to traditional methods like mammograms and colonoscopies, potentially increasing early detection rates.
The product addresses customer aversion to invasive procedures, the high cost associated with some diagnostic tests, and the inconvenience of scheduling and attending appointments for traditional screenings.